From the experiments in 2021, we selected fungal isolates according to morphology from each treatment to confirm their identity using genetic analysis (simple sequence repeats; SSR). Isolates were spread on CM plates covered with filter paper. After 4–5 days of incubation, the mycelia were scraped off the filters, transferred to 2 mL Eppendorf tubes and frozen at -70°C. The frozen mycelia were lyophilized, and cells were disrupted with glass beads (3 mm and 1 mm) in a FastPrep-24 homogenizer (MP Biomedicals, Eschwege, Germany; 25 s at 6 m s-1). We extracted the DNA (sbeadex plant kit and King Fisher Flex Purification system, Thermo Fisher Scientific, Waltham, Massachusetts) and standardized the samples to 5 ng DNA μL-1.
We used six SSR markers in two primer pair sets for each species to analyze fungal genotypes (Bb1F4, Bb2A3, Bb2F8, Bb4H9, Bb5F4, Bb8D6 for B. brongniartii; 47 (link); Ma2049, Ma2054, Ma2063, Ma2287, Ma327, Ma195 for M. brunneum; 48 (link), 49 (link)). Reference strains were included for both species (B. brongniartii, Bip2 and Bip4; Metarhizium spp., Ma714, Ma500 and Bip5). Multiplex PCRs and fragment size analyses were performed as described by Mayerhofer et al. (50 (link)) and Fernandez-Bravo et al. (51 (link)).
Free full text: Click here